Kopkan, Libor <br/><br/>
Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.  [electronic resource] 

 -  Vascular pharmacology   
 - 175-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-3649 
<br/><br/><label>Standard No.: </label>10.1016/j.vph.2009.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetophenones--pharmacology<br/>Analysis of Variance<br/>Angiotensin II--analysis<br/>Animals<br/>Antioxidants--pharmacology<br/>Blood Pressure<br/>Cardiomegaly--complications<br/>Cyclic N-Oxides--pharmacology<br/>Dinoprost--analogs & derivatives<br/>Disease Models, Animal<br/>Free Radical Scavengers--pharmacology<br/>Hypertension--complications<br/>Kidney--chemistry<br/>Kidney Diseases--complications<br/>Male<br/>Malondialdehyde--analysis<br/>Myocardium--chemistry<br/>Oxidative Stress--physiology<br/>Proteinuria<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Transgenic<br/>Renin--genetics<br/>Spin Labels<br/>Time Factors